Wasatch Advisors’s Apyx Medical APYX Stock Holding History

Wasatch Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-200,000	Closed	-$718K	–	346
2016 Q4	$718K	Sell	200,000 -100,000	-33%	-$446K	0.01%	320
2016 Q3	$1.56M	Sell	300,000 -40,000	-12%	-$130K	0.02%	280
2016 Q2	$558K	Hold	340,000	–	–	0.01%	342
2016 Q1	$602K	Sell	340,000 -100,000	-23%	-$201K	0.01%	340
2015 Q4	$924K	Buy	440,000 +100,000	+29%	+$193K	0.01%	337
2015 Q3	$673K	Buy	340,000 +40,000	+13%	+$91.7K	0.01%	341
2015 Q2	$837K	Hold	300,000	–	–	0.01%	350
2015 Q1	$717K	Buy	+300,000	New	+$998K	0.01%	356

Other funds holding APYX

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Wasatch Advisors's APYX Position: Q1 2017 in Review

Wasatch Advisors sold out of Apyx Medical (APYX) in Q1 2017, closing a stake of 200,000 shares — an estimated $718K sold.

Wasatch Advisors first reported a position in APYX in Q1 2015 and held it in 8 quarters. The position peaked at $1.56M in Q3 2016. 37 funds tracked by Wall St. Rank hold APYX as of Q1 2017.

Wasatch Advisors reported no remaining Apyx Medical position as of Q1 2017 after selling out during the quarter.
Wasatch Advisors sold 200,000 Apyx Medical shares in Q1 2017, an estimated $718K.
Wasatch Advisors first reported a position in Apyx Medical in Q1 2015 and held it in 8 quarters.
Wasatch Advisors's Apyx Medical position peaked at $1.56M in Q3 2016.
37 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2017.

Based on Wasatch Advisors's 13F filing for Q1 2017, filed 15 May 2017.